Intracellular glutathione redox status modulates MCP-1 expression in pulmonary granulomatous vasculitis

Laboratory Investigation

Volumn 79, Issue 7, 1999, Pages 837-847

  Desai, Anjali ^a   Huang, Xiaodong ^a   Warren, Jeffrey S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTHIONINE SULFOXIMINE; CHEMOKINE; CYTOKINE; GLUCAN; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; LUNG GRANULOMA; MALE; MONOCYTE; NEUTROPHIL; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; GLUCANS; GLUTATHIONE; LUNG DISEASES; MALE; NF-KAPPA B; OXIDATION-REDUCTION; RATS; RATS, LONG-EVANS; TRANSCRIPTION FACTOR AP-1; VASCULITIS;

EID: 0032808074     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Adcock AM, Peters MJ, Brown CR, Gelder CM, and Barnes PJ (1993). Transcription factor interaction in human lung. Biochem Soc Trans 21:277S.
2. Anderson ME (1997). Glutathione and glutathione delivery compounds. Adv Pharmacol 38:65-78.
3. Barhoumi R, Hartford Bailey R, and Burghardt RC (1995). Kinetic analysis of glutathione in anchored cells with mono-chlorobimane. Cytometry 19:226-234.
4. Barnes PJ (1996). Transcription factors and inflammatory disease. Hosp Pract 25:93-106.
5. Bilimoria MH and Ecobichon DJ (1992). Protective antioxidant mechanisms in rat and guinea pig tissue challenged by acute exposure to cigarette smoke. Toxicology 72:131-144.
6. Blackwell TS and Christman JW (1997). The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol 17:3-9.
7. Bollag DM and Edelstein SJ (1991). Gel electrophoresis under denaturing conditions. In: Bollag DM and Edelstein SJ, editors. Protein methods. New York: Wiley-Liss, 115.
8. Brennan P and O'Neill LAJ (1995). Effects of oxidants and antioxidants on nuclear factor κB activation in three different cell lines: Evidence against a universal hypothesis involving oxygen radicals. Biochim Biophys Acta 1260:167-175.
9. Chandrasekar B and Freeman GL (1997). Induction of nuclear factor κB and activation protein 1 in postischemic myocardium. FEBS Letters 401:30-34.
10. Crapo JD, Peters-Golden M, Mash-Salin J, and Shelburne JS (1978). Pathologic changes in the lungs of oxygen-adapted rats. Lab Invest 39(6):640-653.
11. Deryckere F and Gannon F (1991). A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissue. Nucleic Acids Res 16(3):237.
12. Faruqi RM, Poptic EJ, Ruhe Faruqi T, De la Motte C, and DiCorleto PE (1997). Distinct mechanisms form N-acetylcysteine inhibition of cytokine-induced E-selectin and VCAM-1 expression. Am J Physiol 273:H817-H826.
13. Flohé L, Brigelius-Flohé R, Saliou C, Traber MG, and Packer L (1997). Redox regulation of NF-κB activation. Free Radic Biol Med 22(6):1115-1126.
14. Flory CM, Jones ML, Miller BF, and Warren JS (1995). Regulatory roles of tumor necrosis factor-α and interleukin-1β in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat. Am J Pathol 146:450-462.
15. Flory CM, Jones ML, and Warren JS (1993). Pulmonary granuloma formation in the rat is partially dependent on monocyte chemoattractant protein-1. Lab Invest 69(4):396-404.
16. Foletta VC, Segal DH, and Cohen DR (1997). Transcriptional regulation in the immune system: All roads lead to AP-1. J Leukoc Biol 63:139-152.
17. Furuke K, Sasada T, Ueda-Taniguchi Y, Yamauchi A, Inamoto T, Yamaoka Y, Masutani H, and Yodoi J (1997). Role of intracellular redox status in apoptosis induction of human T-cell leukemia virus type I-infected lymphocytes by 13-cis-retinoic acid. Cancer Res 57:4916-4923.
18. Gómez del Arco P, Martínez-Martínez S, Calvo V, Armesilla AL, and Redondo JM (1997). Antioxidants and AP-1 activation: A brief overview. Immunobiology 198:273-278.
19. 2. J Clin Invest 89:794-802.
20. Israël N, Gougerot-Pocidalo M, Aillet F, and Virelizier J (1992). Redox status of cells influences constitutive or induced NF-κB translocation and HIV long terminal repeat activity in human T and monocytic cells lines. J Immunol 149(10):3386-3393.
21. Jones ML and Warren JS (1992). Monocyte chemoattractant protein-1 in a rat model of pulmonary granulomatosis. Lab Invest 66:498-509.
22. Kilgore KS, Imlay MM, Szaflarski JP, Silverstein FS, Malani, Evans VM, and Warren JS (1997). Neutrophils and reactive oxygen intermediates mediate glucan-induced pulmonary granuloma formation through the local induction of monocyte chemoattractant protein-1. Lab Invest 76(2):191-201.
23. Kopp EB and Ghosh S (1995). NF-κB and Rel proteins in innate immunity. Adv Immunol 58:1-27.
24. Marcho Z, White JE, Higgins PJ, and Tsan, M (1991). Tumor necrosis factor enhances endothelial cell susceptibility to oxygen toxicity: Role of glutathione. Am J Respir Cell Mol Biol 5:556-562.
25. Mårtensson J, Jain A, Stole E, Frayer W, Auld PAM, and Meister A (1991). Inhibition of glutathione synthesis in the newborn rat: A model for endogenously produced oxidative stress. Proc Natl Acad Sci USA 88:9360-9364.
26. Martin T, Cardarelli PM, Parry GCN, Felts KA, and Cobb RR (1997). Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-κB and AP-1. Eur J Immunol 27(5):1091-1097.
27. Marumo T, Schini-Kerth V, Fisslthaler B, and Busse R (1997). Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-κB and expression of monocyte chemoattractant protein-1 in human aortic smooth muscle cells. Circulation 96:2361-2367.
28. Meister A (1991). Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol Therap 51:155-194.
29. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12:5:2005-2015.
30. Muñoz C, Pascual-Salcedo D, Del Carmen Castellanos M, Alfranca A, Aragones J, Vara A, Redondo JM, and De Landazuri MO (1996). Pyrrolidine dithiocarbamate inhibits production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: Modulation of NF-κB and AP-1 transcription factor activity. Blood 88(9): 3482-3490.
31. 4 production. Am Rev Respir Dis 140:1210-1215.
32. Piette J, Piret B, Bonizzi G, Schoonbroodt S, Merville M-P, Legrand-Poels S, and Bours V (1997). Multiple redox regulation in NF-κB transcription factor activation. Biol Chem 378:1237-1245.
33. Read MA, Whitley MZ, Williams AJ, and Collins T (1994). NF-κB and IκBα: An inducible regulatory system in endothelial activation. J Exp Med 179:503-512.
34. Robinson DS, Richeldi L, Saltini C, and Du Bois RM (1997). Granulomatous processes. In: Crystal RG, West JB, Weibel ER, and Barnes PJ, editors. The lung: Scientific foundations, 2nd ed. Philadelphia: Lippincott-Raven Publishers, 2395-2409.
35. Rollins BR, Yoshimura T, Leonard EJ, and Pober JS (1990). Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 136(6):1229-1233.
36. Rovin BH, Dickerson JA, Tan LC, and Fassler J (1997). Modulation of IL-1-induced chemokine expression in human mesangial cells through alterations in redox status. Cytokine 9(3):178-186.
37. Schenk H, Klein M, Erdbrügger W, Dröge W, and Schulze-Osthoff K (1994). Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Cell Biol 91:1677-1681.
38. Schmidt KN, Amstad P, Cerutti P, and Baeuerle PA (1996). Identification of hydrogen peroxide as the relevant messenger in the activation pathway of transcription factor NF-κB. Adv Exp Biol Med 387:63-68.
39. Sen CK, Khanna S, Reznick AZ, Roy S, and Packer L (1997). Glutathione regulation of tumor necrosis factor-alpha-induced NF-kappa B activation in skeletal muscle-derived L6 cells. Biochem Biophys Res Commun 237(3): 645-649.
40. Sen CK and Packer L (1996). Antioxidant and redox regulation of gene transcription. FASEB J 10:709-720.
41. Siebenlist U, Franzoso G, and Brown K (1994). Structure, regulation and function of NF-κB. Ann Rev Cell Biol 10:405-455.
42. Smith PK, Krohn RI, Hermanso GT, Mallia AK, Gartner AK, Provenzano EK, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
43. Sohal RS, Toy PL, and Farmer KJ (1987). Age-related changes in the redox status of the housefly Musca domestica. Arch Gerontol Geriatr 6:95-100.
44. Strieter RM and Kunkel SL (1997). Chemokines. In: Crystal RG, West JB, Weibel ER, and Barnes PJ, editors. The lung: Scientific foundations, 2nd ed. Philadelphia: Lippincott-Raven Publishers, 155-186.
45. Suzuki YJ, Mizuno M, and Packer L (1995). Transient overexpression of catalase does not inhibit TNF-or PMA-induced NF-κB activation. Biochem Biophys Res Commun 210:2: 537-541.
46. Winyard PG and Blake DR (1997). Antioxidants, redox-regulated transcription factors, and inflammation. Adv Pharmacol 38:403-421.
47. Wung BS, Cheng JJ, Hsieh HJ, Shyy YJ, and Wang DL (1997). Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1. Circ Res 81(1):1-7.
48. Zwacka RM, Zhou W, Zhang Y, Darby CJ, Dudus L, Halldorson J, Oberley L, and Engelhardt (1998). Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-κB activation. Nat Med 4:6:698-704.